离子通道的病理生理学 缩性侧面硬化症中的离子通道
Robin N Stringer1,2, Norbert Weiss3,4
1Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
Molecular brain
|December 16, 2023
概括
肌缩侧面硬化症 (ALS) 是一种运动神经元疾病,甚至在症状出现之前就涉及到改变的离子通道和神经元刺激性. 针对这些离子通道变化为ALS提供了潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 道病变是一种通道病变.
背景情况:
- 肌缩侧面硬化症 (ALS) 是最常见和最严重的运动神经元疾病.
- 它导致渐进的运动神经元损失,肌肉衰弱和死亡.
- 虽然ALS的根本原因通常是未知的,但离子通道功能障碍是其关键特征.
研究的目的:
- 在ALS中审查离子通道重塑和改变神经元刺激性.
- 探索这些变化对神经元活动的影响.
- 讨论离子通道作为ALS的潜在治疗点.
主要方法:
- 审查关于ALS的现有文献.
- 对ALS患者和临床前模型的发现进行分析.
- 检查离子通道变化及其对神经元功能的影响.
主要成果:
- 离子通道重塑和神经元刺激能力的改变是ALS的特征.
- 这些变化发生在症状和前症状阶段.
- 该审查强调了与ALS病变发生相关的特定离子通道功能障碍.
结论:
- 离子通道变化是ALS的一个重要标志.
- 了解这些变化对于开发有效的治疗方法至关重要.
- 向离子通道为管理ALS提供了一个有希望的治疗途径.
相关概念视频
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.3K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.3K
Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
Cross-bridge Cycle
117.5K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.5K
Voltage-gated Ion Channels
8.2K
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
8.2K
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556


